CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
Why CRISPR Therapeutics (CRSP) Soared on Friday?
We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going to take a look at where ...
Market Whales and Their Recent Bets on CRSP Options
In terms of liquidity and interest, the mean open interest for CRISPR Therapeutics options trades today is 628.14 with a total volume of 1,152.00.
Allworth Financial LP Purchases 14,398 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
Allworth Financial LP lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2,117.4% during ...
Brokerages Set CRISPR Therapeutics AG (NASDAQ:CRSP) Target Price at $74.50
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-two ...
CRISPR set to snap six days of gains as shares trade in red
CRISPR Therapeutics (CRSP) stock slips after a strong rally driven by earnings beats and analyst upgrades. Explore future catalysts and investment insights.
Citi Sticks to Their Buy Rating for Crispr Therapeutics AG (CRSP)
Citi analyst Yigal Nochomovitz maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price target of ...
Crispr Therapeutics price target lowered to $82 from $89 at Citi
Citi analyst Yigal Nochomovitz lowered the firm’s price target on Crispr Therapeutics (CRSP) to $82 from $89 and keeps a Buy rating on the ...
24/7 Wall St. on MSN1h
VOO vs. VTI: Which Vanguard ETF Is the Better Core Holding?
Retail investors are getting into the idea of passive investing and we’ve seen a steady increase in the funds poured into ...